Login / Signup

Novel intravesical therapeutics in the treatment of non-muscle invasive bladder cancer: Horizon scanning.

Kelly WardMark O KitchenSuresh-Jay MathiasFarhat L KhanimRichard T Bryan
Published in: Frontiers in surgery (2022)
Novel therapeutic agents and drug delivery systems will be important in the future intravesical management of NMIBC. As our understanding of the molecular diversity of NMIBC develops, molecular subtyping will become fundamental in the personalisation of intravesical treatments. Further randomised studies are urgently required to investigate the efficacy of novel intravesical treatments and novel regimens, in comparison to current standards-of-care, particularly in the context of international BCG shortages.
Keyphrases